Italy Neurology Devices Industry

Italy Neurology Devices Market Analysis

The Italy Neurology Devices Market is expected to register a CAGR of 5.8% during the forecast period.

Italy Neurology Devices Market Trends

Cerebrospinal Fluid Management Segment is Expected to Show Better Growth in the Forecast Years

Based on type of device, the market is segmented into cerebrospinal fluid management device, interventional neurology device, neurostimulation device and other type of devices. Cerebral spinal fluid (CSF) shunt systems are used to treat hydrocephalus, which is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. The CSF imbalance can lead to elevated intracranial pressure (ICP), which can lead to a variety of complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. The need for diagnosis and treatment of neurological disorders have made significant progress in recent years, which is expected to drive the market growth in the forecast period.

Italy Neurology Devices Industry Overview

The global players in the Italy neurology devices market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Penumbra Inc., Smith & Nephew plc, and Stryker Corporation.

Italy Neurology Devices Market Leaders